FI106562B - Förfarande för aktivering av en blodkoagulationsfaktor - Google Patents

Förfarande för aktivering av en blodkoagulationsfaktor Download PDF

Info

Publication number
FI106562B
FI106562B FI931554A FI931554A FI106562B FI 106562 B FI106562 B FI 106562B FI 931554 A FI931554 A FI 931554A FI 931554 A FI931554 A FI 931554A FI 106562 B FI106562 B FI 106562B
Authority
FI
Finland
Prior art keywords
prothrombin
factor
blood coagulation
trypsin
thrombin
Prior art date
Application number
FI931554A
Other languages
English (en)
Finnish (fi)
Other versions
FI931554A0 (fi
FI931554A (fi
Inventor
Yendra Linnau
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of FI931554A0 publication Critical patent/FI931554A0/fi
Publication of FI931554A publication Critical patent/FI931554A/fi
Application granted granted Critical
Publication of FI106562B publication Critical patent/FI106562B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)

Claims (4)

1. Forfarande för aktivering av en av blodkoagulations-faktorerna protrombin, faktor IX eller faktor X medelst 5 trypsin, kännetecknat- av att s - blodkoagulationsfaktorn utvinnes ur en protrombin-komplexhaltig fraktion, - den behandlas med trypsin, sora är immobiliserad pä ett vattenolösligt bärmedel, och 10. den immobiliserade trypsinen avskiljes efter aktivering av blodkoagulationsfaktorn.
2. Forfarande enligt patentkrav 1, kännetecknat av att som blodkoagulationsfaktor används protrombin. 15
3. Forfarande enligt patentkrav 1, kännetecknat av att aktiveringen av protrombinen, av faktorn IX eller av faktorn X genomförs vid ett ph-värde av 5,8 - 7,9, en konduktivitet av 5 - 25 mS och en temperatur av 2 - 45 °C. 20
4. Användningen av förfarandet enligt patentkrav 3 för att utvinna trombin ur protrombin. • · I1 · • · · • · • · • · · » » · • · · • Il • · « · « · · * 1 1 • « «·· ( I « « < I 4 I · 4 4« • •44« • ·
FI931554A 1992-04-06 1993-04-06 Förfarande för aktivering av en blodkoagulationsfaktor FI106562B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT71392 1992-04-06
AT0071392A AT396937B (de) 1992-04-06 1992-04-06 Verfahren zur aktivierung von blutgerinnungsfaktoren

Publications (3)

Publication Number Publication Date
FI931554A0 FI931554A0 (fi) 1993-04-06
FI931554A FI931554A (fi) 1993-10-07
FI106562B true FI106562B (sv) 2001-02-28

Family

ID=3497847

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931554A FI106562B (sv) 1992-04-06 1993-04-06 Förfarande för aktivering av en blodkoagulationsfaktor

Country Status (15)

Country Link
US (1) US5393666A (sv)
EP (1) EP0565512B1 (sv)
JP (1) JP2723445B2 (sv)
AT (2) AT396937B (sv)
AU (1) AU663573B2 (sv)
CA (1) CA2092158A1 (sv)
CZ (1) CZ279602B6 (sv)
DE (1) DE59309217D1 (sv)
DK (1) DK0565512T3 (sv)
ES (1) ES2125971T3 (sv)
FI (1) FI106562B (sv)
HU (1) HU216316B (sv)
NO (1) NO306351B1 (sv)
PL (1) PL298391A1 (sv)
SK (1) SK281266B6 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK83092D0 (da) * 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
AT404597B (de) * 1995-11-24 1998-12-28 Immuno Ag Verfahren zur herstellung von proteinen
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US5844087A (en) * 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6461834B1 (en) 1998-11-06 2002-10-08 Bionebraska, Inc. Clostripain catalyzed amidation of peptides
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
CA2631715C (en) * 2005-12-22 2013-07-16 Zymogenetics, Inc. Method for activating prethrombin-1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
JPS59225064A (ja) * 1983-06-03 1984-12-18 ユニチカ株式会社 生理活性物質固定化用担体
AT385657B (de) * 1984-03-09 1988-05-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
EP0294851A3 (de) * 1987-06-12 1990-05-09 Berlin-Chemie Ag Verfahren zur Herstellung von Humaninsulin und seinen Derivaten

Also Published As

Publication number Publication date
HU9300753D0 (en) 1993-06-28
CZ53193A3 (en) 1994-01-19
EP0565512A1 (de) 1993-10-13
NO306351B1 (no) 1999-10-25
HUT68586A (en) 1995-06-28
AU663573B2 (en) 1995-10-12
HU216316B (hu) 1999-06-28
JP2723445B2 (ja) 1998-03-09
SK281266B6 (sk) 2001-01-18
DE59309217D1 (de) 1999-01-28
EP0565512B1 (de) 1998-12-16
NO931221D0 (no) 1993-03-31
ES2125971T3 (es) 1999-03-16
JPH0686674A (ja) 1994-03-29
AT396937B (de) 1993-12-27
US5393666A (en) 1995-02-28
CA2092158A1 (en) 1993-10-07
CZ279602B6 (cs) 1995-05-17
AU3562293A (en) 1993-10-07
SK30893A3 (en) 1993-11-10
FI931554A0 (fi) 1993-04-06
ATE174624T1 (de) 1999-01-15
PL298391A1 (en) 1993-10-18
NO931221L (no) 1993-10-07
DK0565512T3 (da) 1999-08-23
ATA71392A (de) 1993-05-15
FI931554A (fi) 1993-10-07

Similar Documents

Publication Publication Date Title
FI104378B (sv) Förfarande för framställning av trombin
FR2679251A1 (fr) Procede de preparation d&#39;un concentre de thrombine humaine destine a un usage therapeutique.
EA002149B1 (ru) Улучшенные способы приготовления активированного белка с
JP2002518411A (ja) 薬学的第ｖｉｉ因子調製物
FI106562B (sv) Förfarande för aktivering av en blodkoagulationsfaktor
AU737566B2 (en) An immunotolerant prothrombin complex preparation
JPH10509436A (ja) 被阻害形態の被活性化血液因子の生成方法
CA2105282C (en) Preparation of factor ix
JP2832129B2 (ja) 酵素的分解によるタンパク質の切断方法およびその利用方法
KR100383063B1 (ko) 사람활성화단백질c제제및이의제조방법
EP0823476B1 (en) Method for activating prothrombin to thrombin
JP4180671B2 (ja) タンパク質の調製および回収方法
US5945103A (en) Process for producing thrombin
AU740727B2 (en) Activated vitamin K-dependent blood factor and method for the production thereof
JP5167146B2 (ja) プレトロンビン−１の活性化方法
WO2004050700A1 (en) Process for preparating concentrated thrombin solutions and use in fibrin glue
MXPA99008147A (en) Activated vitamin k-dependent blood factor and method for the production thereof
MXPA99008941A (es) Preparacion del complejo de protrombina inmunotolerante